List view / Grid view
22 January 2013 | By Weber Shandwick
Celgene UK and Ireland announced that its phase III clinical trial of ABRAXANE® (nab-paclitaxel) in combination with gemcitabine in treatment-naïve patients with metastatic pancreatic cancer demonstrated a statistically significant improvement in overall survival...
22 January 2013 | By kdm communications
Tecan and IBBL have co-developed an automated platform for buffy coat extraction based on a Freedom EVO® 200 workstation...
22 January 2013 | By Pfizer
Pfizer celebrates 10th anniversary of this signature social investment program...
22 January 2013 | By Novartis
Bexsero®, first vaccine to prevent the leading cause of life-threatening meningitis across Europe...
22 January 2013 | By GlaxoSmithKline
As a global healthcare company, at GSK we believe we have a responsibility to help people make healthier choices...
21 January 2013 | By Novo Nordisk
“We look forward to making Tresiba® and Ryzodeg® available to many people with diabetes in Europe”
18 January 2013 | By Pfizer
“We are very pleased with this positive recommendation on bosutinib by the CHMP..."
18 January 2013 | By Novartis
"Novartis welcomes the decision by the CHMP in support of the approval of Ilaris in the EU"
18 January 2013 | By Novartis
Jetrea(TM) would become the first drug to treat sight-threatening vitreomacular traction and macular hole...
Hyglos has announced the commercial launch of EndoZyme®, a homogeneous fluorescence microplate assay using recombinant Factor C derived from horseshoe crab, for measuring endotoxin (Lipopolysaccharides, LPS) in pharmaceuticals, biologics and medical equipment.
17 January 2013 | By Boehringer Ingelheim
Submissions opened for diabetes research grant applications from across Europe...
17 January 2013 | By Johnson & Johnson
Veridex LLC announced an agreement with LabCorp Clinical Trials...
17 January 2013 | By Novartis
"The challenges in delivering healthcare in developing countries are considerable..."
17 January 2013 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb appoints Mike Burgess...
17 January 2013 | By Boehringer Ingelheim
"Diabetes affects more than 371m people..."
